glp-1 management digital health startups The effect on MedTech Startups, big players ramp up

Obes Surg 31:42164218 Suliman M et al (2019) Routine clinical use of liraglutide 3 mg for the treatment of obesity: outcomes in non-surgical and bariatric surgery patients

Combining phentermine and Wegovy (semaglutide) is not recommended because both drugs affect appetite through different mechanismsphentermine stimulates your nervous system while semaglutide activates GLP-1 receptorscreating unpredictable cardiovascular effects and increasing the risk of heart palpitations, elevated blood pressure, and arrhythmias

Hers provides plan-based check-ins within a larger ecosystem of womens health services, but provider guidance is mostly asynchronous, with limited guidance

For this reason, they are referred to as prandial GLP-1 receptor agonists